Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Scott Maddalo

Pain Medicine New York, NY Medical Doctor

NPI 1316367139 CMS profile 7057895

1 W 34Th St Rm 402A, New York, NY 10001

Open in the dashboard

General payments

$21,594

127 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Scott Maddalo of New York, NY is reported in the CMS Open Payments database as having received $21,594 across 127 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21 1
2024 General $6 1
2022 General $1,966 28
2021 General $10,036 27
2020 General $1,984 16
2019 General $7,580 54

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Maddalo
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Scott Maddalo were reported at $21. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Scott Maddalo Pain Medicine median Middle half National median
2019 $7,580 $498 $126–$1,682 $163
2020 $1,984 $284 $80–$910 $114
2021 $10,036 $399 $112–$1,219 $132
2022 $1,966 $455 $137–$1,484 $149
2023 $0 $484 $128–$1,495 $160
2024 $6 $498 $131–$1,540 $164
2025 $21 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. NeuroMetrix Inc $9,259 2 payments
  2. Medtronic USA, Inc. $3,971 15 payments
  3. Nevro Corp. $1,593 17 payments
  4. Relievant Medsystems, Inc. $1,324 8 payments
  5. Medtronic, Inc. $1,195 16 payments
  6. Abbott Laboratories $1,175 18 payments
  7. Boston Scientific Corporation $1,102 28 payments
  8. Vertos Medical, Inc. $803 8 payments
  9. Spinal Simplicity, LLC $383 1 payment
  10. Pacira Pharmaceuticals Incorporated $312 1 payment
  11. Other $475 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Gift $9,259 2 payments
  2. Food and Beverage $5,351 100 payments
  3. Travel and Lodging $4,377 23 payments
  4. Grant $2,500 1 payment
  5. Entertainment $106 1 payment
Products named General payments · program years 2019–2025
  1. Quell $9,259 2 payments
  2. SYNCHROMED $2,526 2 payments
  3. Senza Spinal Cord Stimulation System $1,459 15 payments
  4. INTELLIS Spinal Cord Neurostimulation $1,418 11 payments
  5. Intracept Pain $1,324 8 payments
  6. Intracept Pain $1,324 8 payments
  7. Proclaim Family of SCS IPGs $987 13 payments
  8. INTELLIS Spinal Cord Neurostimulation $940 10 payments
  9. mild Device Kit $803 8 payments
  10. GENERAL PAIN MANAGEMENT $562 12 payments
  11. Other $2,443 49 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

127 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record